- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07692503
How Institutional Guidelines for Urgent Inpatient Surgeries Affect Intensity of Perioperative Cardiovascular Testing
July 8, 2026 updated by: Johns Hopkins University
PERLHS: How Institutional Guidelines for Urgent Inpatient Surgeries Affect Intensity of Perioperative Cardiovascular Testing: A PrePost Study
This study will evaluate the impact of implementing an educational clinical decision support (CDS) tool designed to guide perioperative cardiovascular evaluation for adults undergoing urgent inpatient surgery.
The CDS tool, integrated within the Epic electronic health record via AgileMD, provides evidence-informed recommendations regarding perioperative cardiac testing and specialty consultation based on American Heart Association guidance and multidisciplinary institutional consensus.
The investigators will conduct a retrospective and prospective pre-post observational cohort study comparing perioperative cardiovascular testing intensity, consultation patterns, time to operating room, and clinical outcomes before and after implementation of the tool among adult patients admitted through the emergency department at Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center who undergo urgent surgery.
Data will be obtained from the Core for Clinical Research Data Acquisition (CCDA) and Epic electronic health record, with case-level chart review performed as needed to validate rare outcomes such as major adverse cardiac events.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
3000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Phillip Wagner, MD
- Phone Number: 14128418522
- Email: pwagner6@jh.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults age 18 years or older
- Admitted through the Emergency Department at Johns Hopkins Hospital or Johns Hopkins Bayview Medical Center Undergoing urgent inpatient surgery during the index hospitalization
Exclusion Criteria:
- Elective surgeries,
- Outpatient procedures,
- Procedures followed only by observation or extended-stay recovery rather than inpatient admission,
- Patients younger than 18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Perioperative Cardiovascular Clinical Decision Support
Participants receive standard perioperative care in a health system where an educational clinical decision support tool is available within the Epic electronic health record.
The CDS tool provides evidence-informed, multidisciplinary recommendations regarding perioperative cardiovascular testing, specialty consultation, and institutional workflows for urgent inpatient surgery.
The tool is advisory only, does not automate orders or replace clinician judgment, and clinicians may override or disregard its recommendations at any time.
|
An educational clinical decision support (CDS) tool integrated within the Epic electronic health record via the AgileMD platform that provides evidence-informed recommendations for perioperative cardiovascular evaluation of adults undergoing urgent inpatient surgery.
The tool includes guidance on appropriate cardiovascular testing, specialty consultation, and institutional workflows, based on American Heart Association perioperative recommendations adapted for the inpatient setting through multidisciplinary consensus among hospital medicine, cardiology, anesthesiology, and perioperative medicine stakeholders.
The CDS tool is advisory only, does not automate orders or replace clinician judgment, and clinicians may follow, modify, or disregard its recommendations based on individualized patient assessment.
|
|
No Intervention: Arm 1: Usual Care
Participants receive standard perioperative evaluation and management according to existing institutional practice prior to implementation of the clinical decision support tool.
Clinical decisions regarding cardiovascular testing and specialty consultation are made at the discretion of the treating clinicians without access to the study CDS tool.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of preoperative tests and consult orders
Time Frame: From Presentation to the ED to 6 months post presentation
|
Cardiovascular Testing and Consultative Intensity.
Rate of preoperative tests and consult orders per patient per admission.
|
From Presentation to the ED to 6 months post presentation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Major Adverse Cardiac Events (MACE)
Time Frame: From presentation at the ED to 6 months post presentation
|
Major Adverse Cardiac Events (MI, Cerebrovascular Accident, Unstable Arrhythmia, Myocardial Injury after Non-cardiac Surgery (MINS), Sudden Cardiac Death)
|
From presentation at the ED to 6 months post presentation
|
|
Time to OR
Time Frame: 0 hours to 5 days
|
Time from Presentation at the ED to start of Surgery
|
0 hours to 5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Phillip Wagner, MD, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
June 1, 2028
Study Registration Dates
First Submitted
July 2, 2026
First Submitted That Met QC Criteria
July 2, 2026
First Posted (Actual)
July 9, 2026
Study Record Updates
Last Update Posted (Actual)
July 10, 2026
Last Update Submitted That Met QC Criteria
July 8, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00554070
- AHRQ-PCORI LHS P30 H5029772 (Other Grant/Funding Number: PCORI)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Adverse Cardiovascular Events
-
Asan Medical CenterSamsung Medical Center; Inje University Haeundae Paik HospitalCompletedLiver Transplantation | Major Adverse Cardiovascular EventsSouth Korea
-
University Hospital, MontpellierRecruitingMajor Adverse Cardiac Events | Adverse Cardiac EventFrance
-
Nanjing Medical UniversityThe First Affiliated Hospital with Nanjing Medical University; West China Hospital and other collaboratorsNot yet recruitingCardiovascular Surgical Procedures | Major Adverse Cardiovascular Events (MACE)China
-
Seoul National University HospitalNot yet recruitingMajor Adverse Cardiovascular and Cerebrovascular Events (MACCE)Korea, Republic of
-
AstraZenecaCompletedMajor Adverse Cardiovascular and Cerebrovascular Events (MACCE)Russian Federation
-
Medstar Health Research InstituteCompletedIncidence of Major Adverse Cardiac EventsUnited States
-
Lin ZhaoRecruitingIn-stent Restenosis | Major Adverse Cardiovascular EventsChina
-
Tianjin Chest HospitalUnknownPercutaneous Coronary Intervention | Saphenous Vein Graft Disease | Major Adverse Cardiovascular Events | Virtual Histology Intravascular UltrasoundChina
-
Xuzhou Central HospitalCompletedAcute Myocardial Infarction (AMI) | Major Adverse Cardiovascular Events | Red Blood Cell Distribution Width-to-albumin RatioChina
-
Qilu Hospital of Shandong UniversityUnknownCardiovascular Death; Major Adverse Cardiovascular EventsChina
Clinical Trials on Educational Clinical Decision Support Tool
-
University of FloridaFogarty International Center of the National Institute of HealthRecruitingTelemedicine | PediatricsHaiti
-
Northwestern UniversityCompletedHeart Failure With Reduced Ejection FractionUnited States
-
Weill Medical College of Cornell UniversityNot yet recruitingPostpartum DepressionUnited States
-
Children's Hospital of PhiladelphiaNational Library of Medicine (NLM)CompletedComprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants (PreemieCDS)PrematurityUnited States
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingHeart Failure | Palliative CareUnited States
-
University of Colorado, DenverAmerican Heart AssociationActive, not recruitingHeart Failure | Decision Support Systems, ClinicalUnited States
-
Oregon Health and Science UniversityEnrolling by invitationAtrial FibrillationUnited States
-
University of Colorado, DenverATI Physical TherapyCompletedTotal Knee ReplacementUnited States
-
Mayo ClinicUniversity of British ColumbiaCompletedSepsis | Shock | Critical Illness | Respiratory Failure | BleedingChina, India, Croatia, Congo, Fiji, Peru
-
Brittany LapinLearning Health Systems Rehabilitation Research NetworkActive, not recruitingPhysical Therapy EvaluationUnited States